STUDresearch · Peptide

HMG (Menotropin)

Also known as

Human Menopausal Gonadotropin · Menopur · hMG 75IU

Community talk. May be wrong. Not medical advice. Not a protocol. Not for human or animal use.

Peptide Niche talk Systemic SubQ / IM Sexual / reproductive

Systemic FSH/LH activity for fertility care; labeled ovarian stimulation differs from off-label male HMG/HCG use.

What people say HMG or menotropins is a urinary-derived prescription gonadotropin preparation supplying FSH and LH activity. MENOPUR is labeled for ovarian stimulation in ART; male fertility discussion is off-label and heavily co-treated. Doses people talk about

Vial activity75 IU FSH plus 75 IU LH activity per vial

MENOPUR product identity, not by itself a daily regimen.

Labeled ovarian-stimulation start225 IU SC daily

Adjusted to ovarian response after day 5, up to 450 IU/day and no more than 20 treatment days.

Off-label male account (unit disputed)75 mg HMG three times weekly as written (unit disputed)

The pregnancy account paired the written HMG amount with 666 IU HCG three times weekly while continuing TRT; a separate reduced-TRT user described thrice-weekly HMG/HCG and injection reactions.

Vial strength, daily ovarian-stimulation dose and off-label male frequency are separate facts. The forum account does not establish a male treatment standard.

Half-life & effect duration

Half-life in the body: Menopur · measured FSHAbout 11–13 hours after injection under the skin or into muscle
Felt duration people report: One injection-reaction accountRedness around 12 hours; pain or bruising lasting days
Fertility outcomesJudged over months in combined regimens

Timing context & sources

How it may feel Fertility benefit is not a same-day subjective effect. MENOPUR has injection and ovarian-stimulation risks; one male forum account described delayed local redness and days of pain or bruising, while pregnancy and semen outcomes were judged over months.

Cycles people discuss The labeled ART course is response-monitored and capped at 20 treatment days. Male forum use spans months with HCG, TRT changes, interruptions or later FSH, so it does not define one HMG cycle. Timing Community accounts describe three-times-weekly HMG/HCG combinations, with differing goals and other treatments; they do not establish one clock-time schedule. Practical timing discussion centers on side effects, training and sleep. Stacks The inspected male reports combine HMG with HCG while continuing or reducing TRT; the combinations confound attribution. Watch for Ovarian hyperstimulation syndrome: MENOPUR can cause OHSS, including serious pulmonary, thromboembolic, renal, and ovarian complications; symptoms can progress rapidly and require clinical monitoring.

Tap a line to jump into the full notes. Research only — may be wrong.

Timing context & sources

Half-life in the body

MENOPUR labeling reports an FSH elimination half-life of approximately 11–13 hours after subcutaneous or intramuscular administration.

The PK study enrolled 33 pituitary-suppressed premenopausal women and examined single then repeated MENOPUR dosing; route-specific mean Tmax differed between SC and IM.

Female ART-product study of FSH immunoreactivity. It does not establish a separate LH-activity half-life, male PK, every menotropin product, or fertility-outcome timing.

DailyMed — MENOPUR (menotropins for injection) prescribing information (opens in a new tab)Description, Dosage and Administration 2.2, Warnings 5.2, Adverse Reactions 6, and Clinical Pharmacology 12.3. Each vial supplies 75 IU FSH and 75 IU LH activity from postmenopausal donor urine; the labeled ART regimen starts at 225 IU SC daily after pituitary suppression, is individualized up to 450 IU/day, and should not exceed 20 days. In 33 pituitary-suppressed premenopausal women, FSH elimination half-life was about 11–13 h after SC or IM MENOPUR.US prescribing information for infertility treatment in women. It does not establish male off-label fertility efficacy, a separate LH-activity half-life, community product identity, or a universal protocol.

Felt duration people report

No therapeutic felt-duration window was established; the inspected male account supplies only a local adverse-reaction chronology.

That account described redness beginning around 12 hours after an injection and pain or bruising lasting days, then a switch after about six weeks. Fertility outcomes were judged over months in combined regimens.

Single anonymous account with unverified product, HCG/TRT co-treatment, interruptions and later FSH substitution. Adverse-reaction timing is not a measure of hormonal persistence or fertility benefit.

Reddit r/Testosterone — TRT, HMG and HCG fertility experiences (opens in a new tab)Post and visible replies: one person reported pregnancy after about three months of combined HMG/HCG while continuing TRT, then wrote 75 mg HMG three times weekly with 666 IU HCG three times weekly. A separate user described HMG/HCG three times weekly while reducing TRT, redness beginning around 12 hours with days of pain/bruising, switching to urofollitropin/FSH after about six weeks, interruptions, and no pregnancy by roughly 3–3.5 months despite promising semen numbers; that user later specified 75 IU FSH.Anonymous, off-label, multi-agent accounts with unverified products and incomplete labs. The pregnancy account writes 75 mg HMG, while MENOPUR is labeled in IU with 75 IU per vial; the thread does not resolve which HMG unit was intended. The separate user's 75 IU figure is for FSH after switching. Pregnancy and semen changes cannot be attributed to HMG alone.

What people say 5

Off-label male discussion: Combined HMG/HCG regimens are discussed for spermatogenesis while modifying or continuing TRT; inspected reports include pregnancy and improving semen numbers, but HMG-specific contribution is unresolved. forum
Libido / function talk: HMG (Menotropin) appears in sexual function and hormone-axis threads. forum
Clinic vs DIY: Prescription products have clearer charts than research-chem clones. forum
Side-effect tradeoffs: Flushing, nausea, or hormone swings often show up before “wins.” forum
Labeled use: MENOPUR is indicated for development of multiple follicles and pregnancy in ovulatory women undergoing assisted reproductive technology. trial

Doses people talk about 4

Off-label male accounts: A pregnancy account wrote 75 mg HMG three times weekly with 666 IU HCG three times weekly while continuing TRT; the HMG unit conflicts with the 75-IU vial label and is unresolved. A separate user described thrice-weekly HMG/HCG while reducing TRT and switched to FSH after injection reactions. These are descriptive multi-agent reports, not a validated male regimen. forum
Clinical culture: stimulation protocols often use multi-day IU totals individualized (vials commonly 75 IU increments). trial
Labeled ART regimen: MENOPUR starts at 225 IU SC daily after pituitary suppression, may be adjusted after 5 days by no more than 150 IU per change, and should not exceed 450 IU/day or 20 treatment days. trial
Framing: Menotropins (hMG) for fertility — IU dosing under clinics. trial

How it may feel 5

After injection: MENOPUR labeling lists injection-site reactions. One off-label male report described redness beginning about 12 hours after HMG and pain or bruising lasting days. forumtrial
Treatment horizon: Labeled ovarian stimulation is monitored day by day and limited to 20 days in a cycle; male fertility reports judge semen or pregnancy over months, not a 10–20 day bioregulator course. forumtrial
No distinctive acute benefit signal: Injection reactions may be noticeable, while fertility endpoints require ultrasound, hormone, semen, or pregnancy follow-up rather than a same-day subjective effect. forumtrial
Days to weeks: In ovarian stimulation, dose response is assessed with ultrasound and estradiol. In the male account, local reactions drove a switch after about six weeks; product interruptions and co-therapy prevent HMG-only attribution. forumtrial
Months in male reports: One combined HMG/HCG/TRT account reported pregnancy around three months; another had no pregnancy by roughly 3–3.5 months despite promising semen numbers. These are conflicting, confounded outcomes. forum

Cycles people discuss 4

Off-label male reports: Multi-month HMG/HCG use appears in fertility discussions, sometimes alongside reduced or continued TRT and later FSH substitution; no universal on/off schedule follows from these accounts. forum
No magic cycle: There is rarely one universal “correct” on/off calendar across forums. forum
Labeled ART cycle: MENOPUR starts after pituitary suppression, is adjusted to ovarian response, and is not administered for more than 20 days; hCG trigger and oocyte retrieval are clinical steps. trial
Reassess: Stop and reassess if adverse effects appear; this is not medical care. forum

Timing 3

Timing practicalities: People time doses around side effects, training, and sleep more than perfect PK. forum
MENOPUR FSH PK: In 33 pituitary-suppressed premenopausal women, FSH elimination half-life was about 11–13 hours after subcutaneous or intramuscular MENOPUR. trial
Boundary: The label's 11–13-hour result is for FSH immunoreactivity in women under the studied MENOPUR regimen; it does not provide a separate LH-activity half-life or predict fertility-result timing. trial

Stacks 2

Multi-bioregulator stacks: Often combined by organ system in protocols. forum
Less is clearer: Solo runs make personal n=1 easier to interpret than five-compound blasts. forum

Storage notes 2

No mix instructions here: STUDresearch does not list reconstitution, diluent volumes, or syringe unit charts. People reconstitute many different ways and vial labels differ — that content creates more confusion than clarity. forum
Storage (general talk only): Unopened research products are usually kept cool, dry, and away from light per the seller label. Anything after first use is product-specific — follow the label, not a universal forum SOP. forum

Related 4

Watch for 6

Allergy / unknown impurities: Gray-market risk. forum
Injection site (if injected): Redness, itch, lumps, bruise — technique and product quality matter. forum
Unknowns: Long-term safety for gray-market preparations is often poorly characterized. forum
Stack noise: Sides logged on multi-agent stacks cannot be blamed cleanly on one compound. forum
Seek care red flags: Severe allergic reaction, chest pain, neuro changes, or uncontrolled BP/glucose need real medical care — not forum advice. forum
Ovarian hyperstimulation syndrome: MENOPUR can cause OHSS, including serious pulmonary, thromboembolic, renal, and ovarian complications; symptoms can progress rapidly and require clinical monitoring. trial

Updated: 2026-08-12

Evidence mix Mostly community / anecdote tags Full: every bullet (trial + community). Use Scan for a faster bro-science read.

↑ Back to top

Half-life & effect duration

Timing context & sources⌄

Half-life in the body

Felt duration people report

What people say 5

Doses people talk about 4

How it may feel 5

Cycles people discuss 4

Timing 3

More on what it is 5

Stacks 2

Storage notes 2

Related 4

Watch for 6

Timing context & sources